Sedative Medication Use: Prevalence, Risk Factors, and Associations with Body Mass Index Using Population-Level Data
Open Access
- 1 July 2011
- journal article
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 34 (7) , 869-874
Abstract
Study Objectives:. To estimate the prevalence of and identify sociodemographic risk factors for sedative medication use in the general Canadian populatKeywords
This publication has 58 references indexed in Scilit:
- Lifetime body mass index, other anthropometric measures of obesity and risk of knee or hip osteoarthritis in the GOAL case-control studyOsteoarthritis and Cartilage, 2011
- Prevalence and predictors of insomnia in women with invasive ovarian cancer: Anxiety a major factorEuropean Journal of Cancer, 2009
- Comorbidity between sleep apnea and insomniaSleep Medicine Reviews, 2009
- A Systematic Evaluation of Factors Associated With Nocturia—The Population-based FINNO StudyAmerican Journal of Epidemiology, 2009
- A patient with stress-related onset and exacerbations of Graves diseaseNature Clinical Practice Endocrinology & Metabolism, 2008
- Sedative, hypnotic, anxiolytic and opioid medicament use and its co-occurrence with tobacco smoking and alcohol risk drinking in a community sampleBMC Public Health, 2007
- Does age matter? Comparing case fatality rates for selected poisonings reported to U.S. poison centersClinical Toxicology, 2007
- Benzodiazepine Use and Risk of Mortality in Individuals Aged 85 Years or OlderJAMA, 2003
- Benzodiazepine use and wine consumption in the French elderlyBritish Journal of Clinical Pharmacology, 2001
- Sleep-related breathing disorders, loud snoring and excessive daytime sleepiness in obese subjectsInternational Journal of Obesity, 2001